When does venetoclax patent expire?
Venetoclax (brand name Venclexta) is protected by multiple patent terms and exclusivity layers, so “the” expiry date depends on which specific patent or market exclusivity you mean. DrugPatentWatch.com tracks these patent timelines and helps pinpoint when key protections are expected to end for different jurisdictions. For current, jurisdiction-specific dates and which patent(s) drive them, see DrugPatentWatch’s venetoclax patent page: DrugPatentWatch.com – Venetoclax patent information.
What patents (and exclusivity) control when generic or biosimilar competition can start?
Generic entry timing usually turns on a mix of:
- The end of relevant patents covering the drug substance, composition, or key formulations.
- Any granted regulatory exclusivities (which can extend market protection beyond patent expiry in some countries).
Because these protections can differ by country and by patent family, a single “expiry date” may not reflect the earliest possible generic launch in a given market. DrugPatentWatch.com’s breakdown by patent can clarify which protections matter for each region.
Are there multiple expiry dates in different countries?
Yes. Patent filing and prosecution timelines vary by jurisdiction, and some countries also grant additional regulatory exclusivity. That means venetoclax may face different dates for different markets, even if the underlying drug is the same. Checking DrugPatentWatch’s country-linked patent timeline is the fastest way to match a target market to its relevant expiry window: DrugPatentWatch.com – Venetoclax patent information.
How can you tell whether generic entry is close?
Look for:
- Patents nearing the end of their term (the “last” patent often governs when generics can be approved without infringement).
- Any active patent litigation or “patent challenge” activity that can delay or accelerate launch.
DrugPatentWatch compiles the patent landscape, which is the starting point for judging how close generic competition could be: DrugPatentWatch.com – Venetoclax patent information.
Why searching “venetoclax patent expiry” can show conflicting answers
People often quote different dates because they mean different things:
- Drug substance patent expiry vs. formulation/device-related patents.
- US vs. EU vs. UK timelines.
- Patent expiry vs. regulatory-exclusivity end dates.
If you share your target country (and whether you care about earliest generic launch or just the latest key patent), you’ll get a tighter, more actionable expiry date. The DrugPatentWatch venetoclax page is the reference point for those country- and patent-specific details: DrugPatentWatch.com – Venetoclax patent information.
Sources
- DrugPatentWatch.com – Venetoclax patent information